Edizzjoni Speċjali bil-Bulgaru: Kapitolu 03 Volum 064 P. 39 - 40
Edizzjoni Speċjali bir-Rumen: Kapitolu 03 Volum 064 P. 39 - 40
EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
You are here
Document 32005R0869
Commission Regulation (EC) No 869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen Text with EEA relevance
Regolament tal-Kummissjoni (KE) Nru 869/2005 tat- 8 ta' Ġunju 2005 li jemenda l-Annessi I u II tar-Regolament tal-Kunsill (KEE) Nru 2377/90 li jistabbilixxi proċedura tal-Komunità għall-iffissar ta' limiti massimi ta' residwi ta' prodotti mediċinali veterinarji fi prodotti tal-ikel ta' oriġini mill-annimali fir-rigward tal-ivermectin u l-carprofen Test b'rilevanza għaż-ŻEE
Regolament tal-Kummissjoni (KE) Nru 869/2005 tat- 8 ta' Ġunju 2005 li jemenda l-Annessi I u II tar-Regolament tal-Kunsill (KEE) Nru 2377/90 li jistabbilixxi proċedura tal-Komunità għall-iffissar ta' limiti massimi ta' residwi ta' prodotti mediċinali veterinarji fi prodotti tal-ikel ta' oriġini mill-annimali fir-rigward tal-ivermectin u l-carprofen Test b'rilevanza għaż-ŻEE
ĠU L 145, 9.6.2005, p. 19–20
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV) Dan id-dokument ġie ppubblikat f’edizzjoni(jiet) speċjali
(BG, RO)
ĠU L 348M, 24.12.2008, p. 113–116
(MT)
No longer in force, Date of end of validity: 05/07/2009; Impliċitament imħassar minn 32009R0470
- Date of document:
- 08/06/2005
- Date of effect:
- 12/06/2005; Dħul fis-seħħ Data tal-pubblikazzjoni + 3 Ara Art. 2
- Date of effect:
- 08/08/2005; Applikazzjoni Ara Art. 2
- Date of end of validity:
- 05/07/2009; Impliċitament imħassar minn 32009R0470
- Author:
- Il-Kummissjoni Ewropea
- Form:
- Regolament
- Additional information:
- Rilevanza għaż-ŻEE, Estiża għaż-ŻEE permezz ta' 22006D0115
- Authentic language:
- Spanjol, Ċek, Daniż, Ġermaniż, Eston, Grieg, Ingliż, Franċiż, Taljan, Latvjan, Litwan, Ungeriż, Malti, Olandiż, Pollakk, Portugiż, Slovakk, Sloven, Finlandiż, Svediż, Islandiż, Norveġiż
- Treaty:
- Trattat li jistabbilixxi l-Komunità Ewropea
- Legal basis:
-
- 31990R2377 - A02 31990R2377 - A03
- Link
- Link
- Link
- Select all documents mentioning this document No data available in the table
- Modifies:
-
Relation Act Comment Subdivision concerned From To Modifies 31990R2377 Emenda anness 2 08/08/2005 Modifies 31990R2377 Emenda anness 1 08/08/2005
No data available in the table
- Modified by:
-
Relation Act Comment Subdivision concerned From To Corrected by 32005R0869R(01) (MT) Implicitly repealed by 32009R0470 06/07/2009 - Instruments cited:
- Link
- Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
Language
HTML
PDF
Official Journal
|
9.6.2005 |
EN |
Official Journal of the European Union |
L 145/19 |
COMMISSION REGULATION (EC) No 869/2005
of 8 June 2005
amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), and in particular Articles 2 and 3 thereof,
Having regard to the opinions of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,
Whereas:
|
(1) |
All pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals should be evaluated in accordance with Regulation (EEC) No 2377/90. |
|
(2) |
Ivermectin has been included in Annex I to Regulation (EEC) No 2377/90 for bovine, porcine, ovine and Equidae for liver and fat and for deer including reindeer for liver, fat, muscle and kidney. That entry should be modified and extended to all mammalian food producing species excluding animals from which milk is produced for human consumption. |
|
(3) |
Carprofen has been included in Annex I to Regulation (EEC) No 2377/90 with carprofen as marker residue for bovine and Equidae for muscle, fat, liver and kidney excluding bovine from which milk is produced for human consumption. That marker residue should be replaced by the sum of carprofen and carprofen glucuronide conjugate. Carprofen should be included in Annex II to that Regulation for bovine milk only. |
|
(4) |
Regulation (EEC) No 2377/90 should be amended accordingly. |
|
(5) |
An adequate period should be allowed before the applicability of this Regulation in order to enable Member States to make any adjustment which may be necessary in the light of this Regulation to the marketing authorisations granted in accordance with Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (2). |
|
(6) |
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products, |
HAS ADOPTED THIS REGULATION:
Article 1
Annexes I and II to Regulation (EEC) No 2377/90 are amended in accordance with the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.
It shall apply from 8 August 2005.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 8 June 2005.
For the Commission
Günter VERHEUGEN
Vice-President
(1) OJ L 224, 18.8.1990, p. 1. Regulation as last amended by Commission Regulation (EC) No 712/2005 (OJ L 120, 12.5.2005, p. 3).
(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28/EC (OJ L 136, 30.4.2004, p. 58).
ANNEX
A. The following substance(s) is(are) inserted in Annex I to Regulation (EEC) No 2377/90
2. Antiparasitic agents
2.3. Agents acting against endo- and ectoparasites
2.3.1. Avermectins
|
Pharmacologically active substance(s) |
Marker residue |
Animal species |
MRLs |
Target tissues |
|
‘Ivermectin |
22,23-Dihydro-avermectin B1a |
All mammalian food-producing species (1) |
100 μg/kg |
Fat |
|
100 μg/kg |
Liver |
|||
|
30 μg/kg |
Kidney |
4. Anti-inflammatory agents
4.1. Nonsteroidal anti-inflammatory agents
4.1.1. Arylpropionic acid derivative
|
Pharmacologically active substance(s) |
Marker residue |
Animal species |
MRLs |
Target tissues |
|
‘Carprofen |
Sum of carprofen and carprofen glucuronide conjugate |
Bovine, equidae |
500 μg/kg |
Muscle |
|
1 000 μg/kg |
Fat |
|||
|
1 000 μg/kg |
Liver |
|||
|
1 000 μg/kg |
Kidney’ |
B. The following substance(s) is(are) inserted in Annex II to Regulation (EEC) No 2377/90
8. Anti-inflammatory agents
|
Pharmacologically active substance(s) |
Animal species |
|
‘Carprofen |
Bovine (2) |
(1) Not for use in animals from which milk is produced for human consumption.’
(2) For bovine milk only.’
All